EYE vs SOM

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

57MEDIUM

SOM

SOMNOMED FPO [SOM]

59MEDIUM

Score Breakdown

EYE SOM
Technical
57
39
Catalyst
53
53
Sentiment
50
50
Fundamental
76
97
Momentum
39
42
Risk Gate
45
47

Key Metrics

EYE Metric SOM
$32.8MMarket Cap$103.0M
269KAvg Volume (20d)193K
N/AShort InterestN/A
$0.20552-Week High$0.945
$0.10052-Week Low$0.462
+0.0%Daily Change+2.1%
$0.115Reference Price$0.480
-42.4%ROE-5.2%
-21.3%Profit Margin-2.2%

Active Signals

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

SOM Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Took a hit — down 12.7% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive

Ask Scout AI to compare EYE and SOM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs SPL →EZZ vs HMD →EZZ vs MEM →EZZ vs MSB →EZZ vs OSL →
EYE Full Analysis → SOM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).